Propanoid Receptor: Key Regulator of Prostaglandin Signaling (P38174)

Target Name: Prostanoid Receptor

NCBI ID: P38174

Prostanoid Receptor

Other Name(s): Prostaglandin receptor | Thromboxane receptor | Prostanoid receptor | Prostacyclin receptor

Propanoid Receptor: Key Regulator of Prostaglandin Signaling

Propanoid Receptor (nonspecified subtype), also known as Prostaglandin receptor, is a protein that plays a crucial role in many physiological processes in the body. It is a family of transmembrane G protein-coupled receptors (GPCRs) that are involved in various signaling pathways, including pain, inflammation, and blood pressure.

The Propanoid Receptor is a non-selective GPCR that can interact with a wide range of ligands, including pro-inflammatory mediators such as prostaglandins. Prostaglandins are a family of naturally occurring compounds that are involved in various physiological processes, including the regulation of pain, inflammation, and blood pressure. They are derived from arachidonic acid, which is a fatty acid that is synthesized in the body and is involved in the production of cellulic acid, which is a component of cell membranes.

The Propanoid Receptor is a key receptor for prostaglandins, which are derived from arachidonic acid. The two main types of prostaglandins are 20-hydroxy-eicosapentaenoic acid (20-H-EPHA) and 14,15-dihydroxy-eicosapentaenoic acid (14,15-DHEA). These compounds are involved in the regulation of various physiological processes, including pain, inflammation, and blood pressure.

The Propanoid Receptor is involved in the regulation of prostaglandin signaling pathways, which are involved in the production and regulation of prostaglandins. Prostaglandins are involved in the regulation of various physiological processes, including the regulation of pain, inflammation, and blood pressure. They are derived from arachidonic acid, which is a fatty acid that is synthesized in the body and is involved in the production of cellulic acid, which is a component of cell membranes.

The Propanoid Receptor is involved in the regulation of prostaglandin signaling pathways, which are involved in the production and regulation of prostaglandins. Prostaglandins are involved in the regulation of various physiological processes, including the regulation of pain, inflammation, and blood pressure. They are derived from arachidonic acid, which is a fatty acid that is synthesized in the body and is involved in the production of cellulic acid, which is a component of cell membranes.

The Propanoid Receptor is a non-selective GPCR that can interact with a wide range of ligands, including pro-inflammatory mediators such as prostaglandins. The interaction between the Propanoid Receptor and prostaglandins allows for the regulation of various physiological processes, including pain, inflammation, and blood pressure.

The Propanoid Receptor is also involved in the regulation of the production of other signaling molecules, including COX and 5-lipoxygenase (5-LO). These molecules are involved in the regulation of various physiological processes, including inflammation and pain.

The Propanoid Receptor is a potential drug target for various diseases, including arthritis, asthma, and heart disease. The inhibition of the Propanoid Receptor has been shown to have therapeutic benefits in these diseases. For example, in the treatment of arthritis, the inhibition of the Propanoid Receptor has been shown to reduce inflammation and pain.

In conclusion, the Propanoid Receptor is a non-selective GPCR that is involved in the regulation of various physiological processes, including pain, inflammation, and blood pressure. It is a key receptor for prostaglandins, which are derived from arachidonic acid and are involved in the regulation of various physiological processes. The inhibition of the Propanoid Receptor has been shown to have therapeutic benefits in

Protein Name: Prostanoid Receptor (nonspecified Subtype)

The "Prostanoid Receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Prostanoid Receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets